-
1
-
-
0019454558
-
Randomised placebo - Controlled trial of hepatitis B vaccine in French haemodialysis unit
-
Crosnier H, Jungers P, Courovice AM, et al. Randomised placebo - controlled trial of hepatitis B vaccine in French haemodialysis unit. Lancet 1981; 1 : 797.
-
(1981)
Lancet
, vol.1
, pp. 797
-
-
Crosnier, H.1
Jungers, P.2
Courovice, A.M.3
-
2
-
-
0021204123
-
Dialysis vaccine trial study group hepatitis B vaccine in haemodialysis patients immuno-genetics and efficacy
-
Cladd E, Stevens MD, Harvey J. Dialysis vaccine trial study group hepatitis B vaccine in haemodialysis patients immuno-genetics and efficacy. N Engl J Med 1984; 311 : 496.
-
(1984)
N Engl J Med
, vol.311
, pp. 496
-
-
Cladd, E.1
Stevens, M.D.2
Harvey, J.3
-
3
-
-
0023483149
-
Selective blockade of antigen receptor mediated pathway of T-cell activation in patients with impaired primary immune response
-
Mener SE, Haur M, Kruz P, et al. Selective blockade of antigen receptor mediated pathway of T-cell activation in patients with impaired primary immune response. J Clin Invest 1987; 80 : 743.
-
(1987)
J Clin Invest
, vol.80
, pp. 743
-
-
Mener, S.E.1
Haur, M.2
Kruz, P.3
-
4
-
-
0024585663
-
Low dose IL-2 induce systemic immune responses against HBsAg in immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination
-
Mener SC, Dumann H, Meyer, Zum K-H, Kohler H. Low dose IL-2 induce systemic immune responses against HBsAg in immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination. Lancet 1989; i : 15.
-
(1989)
Lancet
, vol.1
, pp. 15
-
-
Mener, S.C.1
Dumann, H.2
Meyer3
Zum, K.-H.4
Kohler, H.5
-
5
-
-
0022419320
-
The goanulocyle macrophage colony stimulating factor
-
Metcalf D. The goanulocyle macrophage colony stimulating factor. Science 1985; 229 : 16.
-
(1985)
Science
, vol.229
, pp. 16
-
-
Metcalf, D.1
-
6
-
-
0023244861
-
GM-CSF augments primary immune response by enhancing function of antigen presenting cells
-
Morrisey PJ, Bressler L, Park LS, Alpert A, Gilli S. GM-CSF augments primary immune response by enhancing function of antigen presenting cells. J Immunol 1987; 139 : 1113.
-
(1987)
J Immunol
, vol.139
, pp. 1113
-
-
Morrisey, P.J.1
Bressler, L.2
Park, L.S.3
Alpert, A.4
Gilli, S.5
-
8
-
-
0030133716
-
The effect of granulocyte macrophage colony stimulating factor on hepatitis B vaccination in haemodialysis patients
-
Hess G, Kreiler F, Kosters W. The effect of granulocyte macrophage colony stimulating factor on hepatitis B vaccination in haemodialysis patients. J Viral Hepatitis 1996; 3 : 149-53.
-
(1996)
J Viral Hepatitis
, vol.3
, pp. 149-153
-
-
Hess, G.1
Kreiler, F.2
Kosters, W.3
-
9
-
-
0023696604
-
Enhancement of antibody production on HB vaccine by IL-2
-
Kakumu S, Fuji A, Thara H, Yoshioka K, Sakamato N. Enhancement of antibody production on HB vaccine by IL-2. J Chin Lab Immunol 1988; 26 (1) : 25-7.
-
(1988)
J Chin Lab Immunol
, vol.26
, Issue.1
, pp. 25-27
-
-
Kakumu, S.1
Fuji, A.2
Thara, H.3
Yoshioka, K.4
Sakamato, N.5
-
10
-
-
0038612762
-
Granulocyte macrophage colony stimulating factor on an adjuvant to hepatitis B vaccine in haemodialysis patients. A priliminary report
-
Ananth U, Danraj P, Nayyas V, Ballal HS Granulocyte macrophage colony stimulating factor on an adjuvant to hepatitis B vaccine in haemodialysis patients. A priliminary report. Ind J Nephrology 1997; 7 (3) : 109-11.
-
(1997)
Ind J Nephrology
, vol.7
, Issue.3
, pp. 109-111
-
-
Ananth, U.1
Danraj, P.2
Nayyas, V.3
Ballal, H.S.4
|